Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to Thermo Fisher Scientific for approximately USD 4 billion in cash, subject to customary adjustments, effective 1 September 2025.
The divested business is a leading global provider of purification and filtration technologies used in the production of biologics, as well as in medical technologies and industrial applications. It operates worldwide, with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Paksoy is pleased to announce that a team led by partner Stéphanie Beghe Sönmez and associates Meriç Saçak Albaş and Cansın Taner acted as Turkish counsel to Solventum, alongside Cleary Gottlieb Steen & Hamilton, which served as global counsel on this multijurisdictional transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
20 April 2026
Paksoy advises Carrefour on the sale of its stake in CarrefourSA
On 17 April 2026, Carrefour entered into a share purchase agreement to sell its 32.16% stake in CarrefourSA, one of the major supermarket…
10 April 2026
Paksoy advises Anadolu Efes on the acquisition of a majority stake in Mercan Rakı
Anadolu Group has entered into an agreement to acquire a 60% stake in Tariş Üzüm, the producer of Mercan Rakı.
26 March 2026
We are recognised as top-tier by the Legal 500 EMEA 2026
Once again, our firm and lawyers have been recognised as top-tier by the Legal 500 EMEA 2026.
25 March 2026
Paksoy advises Arch Peninsula on its acquisition of Sanipak
Paksoy advises Arch Peninsula on its acquisition of Sanipak, a leading consumer products company, from Eczacıbaşı Holding for USD 600…
18 March 2026
Once again, we are recognised among the top-tier in the Chambers Europe Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers and Partners Europe 2026.
6 March 2026
Paksoy advises on Türkiye Petrolleri’s landmark USD 4 billion Sukuk Programme and inaugural USD 1 billion issuance
Paksoy is pleased to have advised on the establishment of Türkiye Petrolleri’s USD 4 billion Sukuk Issuance Programme and the successful…
